Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 21, 2025; 31(3): 98688
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.98688
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.98688
DFS | OS | CRR | |
Non-DM group (n = 160) | 34 (21.25) | 27 (16.88) | 12 (7.50) |
DM group (n = 118) | 33 (27.97) | 23 (19.50) | 17 (14.41) |
Well-controlled group (n = 73) | 16 (21.90) | 10 (13.70) | 6 (8.22) |
Poorly controlled group (n = 45) | 17 (37.78) | 13 (28.89) | 11 (24.40) |
P value1 | 0.196 | 0.575 | 0.063 |
P value2 | 0.908 | 0.538 | 0.849 |
P value3 | 0.023a | 0.072 | 0.001a |
P value4 | 0.062 | 0.043a | 0.015a |
- Citation: Guan RY, Wu JW, Yuan ZY, Liu ZY, Liu ZZ, Xiao ZC, Li JH, Huang CZ, Wang JJ, Yao XQ. Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer. World J Gastroenterol 2025; 31(3): 98688
- URL: https://www.wjgnet.com/1007-9327/full/v31/i3/98688.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i3.98688